Author:
Kaufmann Max,Evans Hayley,Schaupp Anna-Lena,Engler Jan Broder,Kaur Gurman,Willing Anne,Kursawe Nina,Schubert Charlotte,Attfield Kathrine E.,Fugger Lars,Friese Manuel A.
Funder
Stifterverband
Wellcome Trust
Oak Foundation
Universitätsklinikum Hamburg-Eppendorf
Medical Research Council
Reference57 articles.
1. Immunopathology of multiple sclerosis;Dendrou;Nat. Rev. Immunol.,2015
2. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis;Polman;N. Engl. J. Med.,2006
3. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension;Kapoor;Lancet Neurol.,2018
4. The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis;Scalfari;Neurology,2018
5. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis;Magliozzi;Ann. Neurol.,2010
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献